Cornèr Banca SA Share Price

Certificat

CVQCBL

CH1203656074

Real-time Bid/Ask 08:38:56 05/07/2024 pm IST
80.53 EUR / 81.33 EUR +0.63% Intraday chart for Cornèr Banca SA
Current month-0.33%
1 month-4.99%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
04/24/04 80.42 -0.09%
03/24/03 80.49 -0.47%
02/24/02 80.87 -1.39%
01/24/01 82.01 +1.64%
28/24/28 80.69 +2.53%

Delayed Quote Swiss Exchange

Last update July 04, 2024 at 08:50 pm IST

More quotes

Static data

Product typeCertificats Divers
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Cornèr Bank Ltd.
CVQCBL
ISINCH1203656074
Date issued 01/05/2023
Maturity 01/11/2024 (119 Days)
Parity 1 : 1
Emission price 100
Emission volume N/A
Settlement les deux
Currency EUR

Technical Indicators

Highest since issue 99.98
Lowest since issue 71.52
Spread 8
Spread %0.99%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
243.4 CHF
Average target price
276.4 CHF
Spread / Average Target
+13.57%
Consensus
  1. Stock Market
  2. Certificates
  3. CVQCBL Certificat